INmune Bio's high-upside potential with CORDStrom for RDEB and XPro for Alzheimer's, offering up to 144.8x returns. Click here to read why INMB is a Strong Buy.

Micron Technology's recent guidance was disappointing. Read more to see why I downgrade MU stock from strong buy to buy.